Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Condensed Consolidated Statements of Operations
Revenues	$ 0	$ 363
Cost of goods sold		225
Gross Income		138
Operating expenses:
Research and development	108	826
General and administrative	1,409	1,333
Total operating expenses	1,517	2,159
Loss from operations	(1,517)	(2,021)
Other income
Gain from sale of assets	23
Other income, net	4
Net Loss	$ (1,490)	$ (2,021)
Net loss per share - basic	$ (0.05)	$ (0.07)
Net loss per share - fully diluted	$ (0.05)	$ (0.07)
Weighted average number of shares outstanding - basic	31,826,221	30,526,571
Weighted average number of shares outstanding - fully diluted	31,826,221	30,526,571